WOW.com Web Search

  1. Ad

    related to: cancer immunosuppression pathway stages 1
    • Cancer Research

      Learn About KP's Demonstrated

      Clinical Trials for Cancer Care.

    • Treating Cancer

      Learn About KP's 360-Degree

      Approach to Treating Cancer.

Search results

  1. Results from the WOW.Com Content Network
  2. Cancer immunology - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunology

    Definition. Cancer immunology is an interdisciplinary branch of biology concerned with the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, where the immune system is used to treat cancer. [1] [2] Cancer immunosurveillance is a theory formulated in 1957 by Burnet ...

  3. Cancer immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunotherapy

    Cancer immunotherapy ( immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology) and a growing subspecialty of oncology . Cancer immunotherapy exploits the fact that ...

  4. Pembrolizumab - Wikipedia

    en.wikipedia.org/wiki/Pembrolizumab

    146 648.64 g·mol −1. Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. [10] [12] [13] [14] It is administered by slow intravenous injection.

  5. Immunoediting - Wikipedia

    en.wikipedia.org/wiki/Immunoediting

    Immunoediting. Immunoediting is a dynamic process that consists of immunosurveillance and tumor progression. It describes the relation between the tumor cells and the immune system. It is made up of three phases: elimination, equilibrium, and escape. [1]

  6. Tumor antigen - Wikipedia

    en.wikipedia.org/wiki/Tumor_antigen

    Tumor antigen is an antigenic substance produced in tumor cells, i.e., it triggers an immune response in the host. Tumor antigens are useful tumor markers in identifying tumor cells with diagnostic tests and are potential candidates for use in cancer therapy. The field of cancer immunology studies such topics.

  7. CD4+ T cells and antitumor immunity - Wikipedia

    en.wikipedia.org/wiki/CD4+_T_cells_and_antitumor...

    The role of CD4 + T cells in antitumor immunity is controversial. It was suggested that CD4 + T cells can have a direct role in antitumor immunity through direct recognition of tumor antigens presented on the surface of tumor cells in association with MHC class II molecules. [1] Of note, results from recent reports suggest that direct ...

  8. Cutaneous squamous-cell carcinoma - Wikipedia

    en.wikipedia.org/wiki/Cutaneous_squamous-cell...

    Cutaneous squamous-cell carcinoma is the second-most common cancer of the skin (after basal-cell carcinoma, but more common than melanoma). It usually occurs in areas exposed to the sun. Sunlight exposure and immunosuppression are risk factors for SCC of the skin, with chronic sun exposure being the strongest environmental risk factor.

  9. Transforming growth factor beta - Wikipedia

    en.wikipedia.org/wiki/Transforming_growth_factor...

    In normal cells, TGF-β, acting through its signaling pathway, stops the cell cycle at the G1 stage to stop proliferation, induce differentiation, or promote apoptosis. In many cancer cells, parts of the TGF-β signaling pathway are mutated, and TGF-β no longer controls the cell. These cancer cells proliferate.

  1. Ad

    related to: cancer immunosuppression pathway stages 1